| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/14/1998 | EP0817839A1 Human dnase |
| 01/14/1998 | EP0817837A1 Culture medium for insect cells |
| 01/14/1998 | EP0817836A1 Cell line and process for multiplying rabies viruses and their quantitative detection |
| 01/14/1998 | EP0817835A1 Production of antibodies using cre-mediated site-specific recombination |
| 01/14/1998 | EP0817834A1 Compartmentalized tissue culture bag |
| 01/14/1998 | EP0817833A1 Filter device |
| 01/14/1998 | EP0817801A1 Antibody to the syncytiotrophoblast antigen r80k and use thereof |
| 01/14/1998 | EP0817800A1 Human g-protein coupled receptors |
| 01/14/1998 | EP0817785A2 Substrates for beta-lactamase and uses thereof |
| 01/14/1998 | EP0770125A4 Primate embryonic stem cells |
| 01/14/1998 | EP0635061B1 A method of limiting the survival of genetically engineered microorganisms in their environment |
| 01/14/1998 | EP0500799B1 Particle mediated transformation of animal skin tissue cells |
| 01/14/1998 | EP0437488B1 Animal model for human disease |
| 01/14/1998 | EP0394277B1 Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same |
| 01/14/1998 | CN1170435A Regulation of neural stem cell proliferation |
| 01/14/1998 | CN1170434A In vitro Induction of dopaminergic cells |
| 01/14/1998 | CN1170415A Cathepsin O2 protease |
| 01/14/1998 | CN1170040A Nucleic acid constructs containing genes encoding transport signals |
| 01/13/1998 | US5708157 Secreted proteins and polynucleotides encoding them |
| 01/13/1998 | US5708143 Protocadherin materials and methods |
| 01/13/1998 | US5708142 Tumor necrosis factor receptor-associated factors |
| 01/13/1998 | US5707868 Enclosure with piston, maintaining constant density for correct embryo development, production of proteins, polyphenols, saponins, terpenes, alkaloids, sterols, retinoids, vitamins |
| 01/13/1998 | US5707865 Retroviral vectors for expression in embryonic cells |
| 01/13/1998 | US5707859 Two-dimensional microcarriers for anchorage dependent cells |
| 01/13/1998 | US5707846 N-acetylglucosaminyl transferase gene coding therefor and process for production thereof |
| 01/13/1998 | US5707844 Immunoassay reagents and methods for detecting brequinar and analogs |
| 01/13/1998 | US5707840 Dna which encodes ribozyme rna coupled with antisense rna, transformed plant cells have improved resistance to disease |
| 01/13/1998 | US5707839 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis |
| 01/13/1998 | US5707832 Culturing eukaryotic cells in medium supplemented with a sulfated polysaccharide |
| 01/13/1998 | US5707829 DNA sequences and secreted proteins encoded thereby |
| 01/13/1998 | US5707815 Polypeptides produced bby expression of heterologous nucleic acid in cells and encoded by dna and hybridize |
| 01/13/1998 | US5707805 Assay for detecting keratinocyte growth factor (KGF) and its activity |
| 01/13/1998 | US5707800 Retinoic acid response elements and assays employing same |
| 01/13/1998 | US5707798 Identification of ligands by selective amplification of cells transfected with receptors |
| 01/13/1998 | US5707795 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 01/13/1998 | US5707632 Immunology |
| 01/13/1998 | US5707616 Method for treating or preventing gastrointestinal disease with epithelium-derived T-cell factor |
| 01/08/1998 | WO1998000555A1 Recombinant n-proteinase, and the production, methods and uses thereof |
| 01/08/1998 | WO1998000554A1 Protease fmh-1, an ice/ced-like protease |
| 01/08/1998 | WO1998000549A1 MANIPULATION OF CELLULOSE AND/OR β-1,4-GLUCAN |
| 01/08/1998 | WO1998000545A2 G protein signal transduction in plants |
| 01/08/1998 | WO1998000544A2 Growth arrest gene compositions and methods |
| 01/08/1998 | WO1998000543A1 Hepatocyte growth factor receptor agonists and uses thereof |
| 01/08/1998 | WO1998000540A1 Human stem cell antigens, dna coding therefor and their use |
| 01/08/1998 | WO1998000537A1 Composition and methods for modulating the length of telomeres |
| 01/08/1998 | WO1998000527A1 ISOLATION AND CLONING OF THE HUMAN hARSA-I GENE AND USES THEREOF |
| 01/08/1998 | WO1998000523A1 Process of obtaining compositions enriched for hematopoietic stem cells and antibodies for use therein |
| 01/08/1998 | WO1998000522A1 Method to produce granulocyte colony stimulating factor from immortalized avian t lymphocytes and method to produce immortalized cells |
| 01/08/1998 | WO1998000521A1 Serum-free media, method for culturing animal cells, and process for producing physiologically active substances |
| 01/08/1998 | WO1998000445A1 Nephropathy-related immunoglobulin g and antibodies for same |
| 01/08/1998 | WO1998000171A2 Conjugates of thrombin inhibitors and endogenes carriers |
| 01/08/1998 | WO1997042327A3 Method for increasing the content of trehalose in organisms through the transformation thereof with the cdna of the trehalose-6-phosphate synthetase/phosphatase of selaginella lepidophylla |
| 01/08/1998 | WO1997035999A3 Production of vanillin |
| 01/08/1998 | WO1997033995A3 Extracellular matrix signalling molecules |
| 01/08/1998 | DE19725602A1 Cell culture chamber |
| 01/08/1998 | DE19626564A1 Genetische Transformation von Ciliatenzellen durch Microcarrier-Bombardement mit DNA beladenen Goldpartikeln Genetic transformation of ciliate by microcarrier bombardment with DNA-loaded gold particles |
| 01/08/1998 | DE19625188A1 System zur Herstellung von AAV-Vektoren System for the production of AAV vectors |
| 01/08/1998 | CA2259389A1 Composition and methods for modulating the length of telomeres |
| 01/08/1998 | CA2259337A1 Growth arrest gene compositions and methods |
| 01/08/1998 | CA2259302A1 Nephropathy-related immunoglobulin g and immune complexes thereof |
| 01/08/1998 | CA2259208A1 Isolation and cloning of the human harsa-i gene and uses thereof |
| 01/08/1998 | CA2259135A1 Human stem cell antigens, dna coding therefor and their use |
| 01/08/1998 | CA2258694A1 G protein signal transduction in plants |
| 01/08/1998 | CA2258516A1 Conjugates of thrombin inhibitors and endogenes carriers |
| 01/08/1998 | CA2205554A1 Novel isoform gene for focal adhesion protein paxillin |
| 01/07/1998 | EP0816504A2 Platelet activating factor acetylhdrolase, and gene thereof |
| 01/07/1998 | EP0816502A2 Mur A-1, an UDP-N-acetylglucosamine enolpyruvyl-transferase from Streptococcus pneumoniae |
| 01/07/1998 | EP0816497A2 Human requiem polypeptide for apoptosis |
| 01/07/1998 | EP0816496A2 T-cells specific for kidney carcinoma |
| 01/07/1998 | EP0816495A1 DNA coding for a peptide promoting the activation of protein C by thrombin and dprocess for producing the same |
| 01/07/1998 | EP0816494A1 DNA coding for a peptide promoting the activation of protein C by thrombin, and process for producing the same |
| 01/07/1998 | EP0816493A1 3'End deleted DNA coding for a peptide promoting the activation of protein C by thrombin, and process for producing the same |
| 01/07/1998 | EP0816488A1 Method of conditioning for in vitro culture plant tissues |
| 01/07/1998 | EP0816380A1 Novel protein and methods for the production of the same |
| 01/07/1998 | EP0815867A1 Cells for treating dementia |
| 01/07/1998 | EP0815866A2 Platelet membrane fragment preparation |
| 01/07/1998 | EP0815450A2 Compounds and methods for the dectection of t. cruzi infection |
| 01/07/1998 | EP0815252A1 Gene therapy for transplantation and inflammatory or thrombotic conditions |
| 01/07/1998 | EP0815251A1 Gene expression in mammalian cells |
| 01/07/1998 | EP0815248A1 Dna constructs and plants incorporating them |
| 01/07/1998 | EP0815245A1 Bioactive fusion proteins and pre-existing tumor therapy |
| 01/07/1998 | EP0815240A1 Novel human cyclin-dependent kinase-like proteins and methods of using the same |
| 01/07/1998 | EP0815237A1 Threonyl-trna synthetase of staphylococcus aureus |
| 01/07/1998 | EP0815232A1 Protein production and delivery |
| 01/07/1998 | EP0815231A2 Use of neuronal apoptosis inhibitor protein (naip) |
| 01/07/1998 | EP0815229A2 Rage tumor rejection antigens |
| 01/07/1998 | EP0815227A1 HUMAN METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE mGluR6, NUCLEIC ACIDS ENCODING SAME AND USES THEREOF |
| 01/07/1998 | EP0815224A1 Receptor activation by gas6 |
| 01/07/1998 | EP0815221A1 A novel growth factor and a genetic sequence encoding same |
| 01/07/1998 | EP0815219A1 Human b-cell translocation genes-2 and 3 |
| 01/07/1998 | EP0815218A2 Human vegf-specific antisense oligonucleotides |
| 01/07/1998 | EP0815214A1 Dna molecules, preparation thereof and use thereof in gene therapy |
| 01/07/1998 | EP0815213A1 An immortalized mammal hybridoma fusion partner |
| 01/07/1998 | EP0815212A1 Novel encapsulation process by a gelling polymer |
| 01/07/1998 | EP0815206A1 Cell culture method |
| 01/07/1998 | EP0815205A1 Method for in vitro preconditioning of myoblasts before transplantation |
| 01/07/1998 | EP0815204A1 Method for treating tumors |
| 01/07/1998 | EP0815203A1 Mesenchymal stem cells for cartilage repair |
| 01/07/1998 | EP0815202A1 Human tissue inhibitor of metalloproteinase-4 |
| 01/07/1998 | EP0815199A1 Human deoxycytidine kinase 2 |